Pneumocystis jirovecii
PRESENTED BY,
JAYAPRIYA R
BP211513
I-M.Sc Microbiology
Sacred Heart College,
GENERAL CHARACTERISTICS :
 Pneumocystis jirovecii, the fungus that causes Pneumocystis
pneumonia.
Till Recently P.jirovecii was thought to be protozozan but is
now considered a fungus. Pneumocystis jirovecii used to be
called
Fungus:Ascomycetes
Class: Pneumocystidomycetes
Family: Pneumocystidaceae
Species: P. jirovecii
Kingdom: Fungi
MORPHOLOGY:
Pneumocystis jirovecii
cysts are
 rounded and
approximately
in size, although thin-
walled cysts exist also.
 Cyst Contains
nuclei.
PATHOGENESIS:
PCP spreads from
Some healthy adults can carry the Pneumocystis fungus in
their and it can spread to
other people, including those with
Disease occurs when both cellular immunity and humoral
immunity are defective.
Once inhaled, the trophic form of Pneumocystis organisms
PATHOGENESIS:
Multiple host immune defects allow for uncontrolled
organisms and development of
illness.
 Activated alveolar macrophages are
unable to eradicate Pneumocystis organisms.
 Increased alveolar-capillary permeability is visible on
electron microscopy.
SYMPTOMS:
Sudden start of Fever
Dry Cough
Difficulty breathing
Chest pain
Chills
Fatigue (tiredness)
With little or No mucus.
LABORATORY DIAGNOSIS:
PCP is diagnosed using a sample from a
The sample is usually that is either coughed up by the
patient Sputum or collected by a procedure called
Sometimes, a small sample of is used to
diagnose PCP.
The patient’s sample is sent to a laboratory, usually to be
Polymerase chain reaction can also be used to detect
Pneumocystis DNA in different types of samples.
A blood test to detect (a part of the cell wall of
many different types of fungi) can also help diagnose PCP.
 PCP must be treated with prescription medicine. Without
treatment,
The most common form of treatment is
trimethoprim/sulfamethoxazole (TMP/SMX), which is also
known as
This medicine is given by or through a
TMP/SMX can cause side effects such as and Other
medicines are available for patients who cannot take
TMP/SMX.
or
TREATMENT:
Pneumocytosis jiroveci.pptx

Pneumocytosis jiroveci.pptx

  • 1.
    Pneumocystis jirovecii PRESENTED BY, JAYAPRIYAR BP211513 I-M.Sc Microbiology Sacred Heart College,
  • 2.
    GENERAL CHARACTERISTICS : Pneumocystis jirovecii, the fungus that causes Pneumocystis pneumonia. Till Recently P.jirovecii was thought to be protozozan but is now considered a fungus. Pneumocystis jirovecii used to be called Fungus:Ascomycetes Class: Pneumocystidomycetes Family: Pneumocystidaceae Species: P. jirovecii Kingdom: Fungi
  • 3.
    MORPHOLOGY: Pneumocystis jirovecii cysts are rounded and approximately in size, although thin- walled cysts exist also.  Cyst Contains nuclei.
  • 4.
    PATHOGENESIS: PCP spreads from Somehealthy adults can carry the Pneumocystis fungus in their and it can spread to other people, including those with Disease occurs when both cellular immunity and humoral immunity are defective. Once inhaled, the trophic form of Pneumocystis organisms
  • 5.
    PATHOGENESIS: Multiple host immunedefects allow for uncontrolled organisms and development of illness.  Activated alveolar macrophages are unable to eradicate Pneumocystis organisms.  Increased alveolar-capillary permeability is visible on electron microscopy.
  • 6.
    SYMPTOMS: Sudden start ofFever Dry Cough Difficulty breathing Chest pain Chills Fatigue (tiredness) With little or No mucus.
  • 8.
    LABORATORY DIAGNOSIS: PCP isdiagnosed using a sample from a The sample is usually that is either coughed up by the patient Sputum or collected by a procedure called Sometimes, a small sample of is used to diagnose PCP.
  • 9.
    The patient’s sampleis sent to a laboratory, usually to be Polymerase chain reaction can also be used to detect Pneumocystis DNA in different types of samples. A blood test to detect (a part of the cell wall of many different types of fungi) can also help diagnose PCP.
  • 10.
     PCP mustbe treated with prescription medicine. Without treatment, The most common form of treatment is trimethoprim/sulfamethoxazole (TMP/SMX), which is also known as This medicine is given by or through a TMP/SMX can cause side effects such as and Other medicines are available for patients who cannot take TMP/SMX. or TREATMENT: